320-x-100_uti_gold.jpg" alt="Advertisement">
Buy Apollo Hospitals Enterprise Ltd For Target Rs.7,764 By Geojit Financial Services Ltd
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Strong Performance, Optimistic Outlook
Apollo Hospitals Enterprise Ltd (Apollo) operates the largest network of hospitals in India with 73 centres and more than 6,000 pharmacies.
* Apollo's consolidated revenue rose 15.6% YoY to Rs. 5,628cr in Q2FY25, driven by notable growth across segments.
* Healthcare services rose 13.8% YoY to Rs. 2,920cr due to a 13% increase in revenue from insured patients and a 15% rise from patients making cash payments. The two sources together account for 83% of the hospital’s inpatient revenue.
* Revenue from digital health and pharmacy distribution climbed 17.3% YoY to Rs. 2,282cr, with average daily orders through pharma and diagnostic consultations increasing from 62,000 per day in Q2FY24 to 76,000 per day in Q2FY25.
* Offline pharmacy distribution revenue stood at Rs. 2,014cr, while Apollo’s digital platform generated Rs. 268cr. Retail health and diagnostics also saw revenue growth of 14.0% YoY to Rs 404cr, driven by higher footfalls.
* EBITDA surged 31.4% YoY to Rs 854cr and margin improved 190bps to 15.2% owing to a higher topline and reduced employee costs as a percentage of revenue
Outlook & Valuation
Apollo delivered a strong financial performance in Q2FY25 on the back of robust revenue growth, an expanding hospital network and innovative healthcare services. Its expansion plans, including the development of a 500-bed hospital at Worli, Mumbai, and the addition of 200 beds at its Lucknow facility, would increase the number of operational beds by 1,400 across key metro markets by FY26, driving growth and profitability. In addition, Apollo’s focus on digital health and diagnostics services is expected to lead to strong growth, while its integrated operations are anticipated to improve operational efficiency and drive synergies. With a strong execution record and growing presence in key metro markets, Apollo is poised to deliver strong returns. Hence, we reiterate our BUY rating on the stock with a revised target price of Rs. 7,764 based on the SOTP valuation
For More Geojit Financial Services Ltd Disclaimer https://www.geojit.com/disclaimer
SEBI Registration Number: INH200000345
